Preserving antibiotics` livesaving power for future generations
The global crisis requires innovation. Selux NGP will help to end the downward spiral of antibiotic resistance and preserve the efficacy of antibiotics in treating Infectious Diseases for posterity.

A diversity of knowledge for a better world
Selux’s interdisciplinary team has expertise in microbiology, biochemistry, chemistry, engineering, software, and algorithm design and is buttressed by distinguished experts in Clinical Microbiology, Infectious Disease, and Machine Learning.

We are facing a global crisis
Bacterial resistance to antibiotics now ranks among the world`s deadliest and costliest health threats.

15 Minutes pass and someone new dies of an antibiotic resistant infection.
2050 The year by which superbugs are expected to surpass cancer as a leading cause of death.
50% of antibiotics used in hospitals are either unnecessary or are prescribed incorrectly.

The new backbone of microbiology
Tested against 800+ FDA-CDC challenge strains, Selux NGP is a revolutionary AST testing platform that provides targeted treatment to save the lives of patients, reduce healthcare costs and drive global change.

The science difference
The science is complicated, but the solution is simple: we see bugs die faster than anyone else.

Selux Diagnostics, Inc. products

Next-Generation Phenotyping (NGP) Technology